Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02954536 |
|---|---|
| Brief Title: | Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer |
| First Submitted : | November 2, 2016 |
| First Submitted that Met QC Criteria : | November 2, 2016 |
| First Posted : | November 3, 2016 (Estimate) |
| Results First Submitted : | January 13, 2023 |
| Results First Submitted that Met QC Criteria : | January 13, 2023 |
| Results First Posted : | February 9, 2023 |
| Last Update Submitted that Met QC Criteria : | March 14, 2023 |
| Last Update Posted : | March 16, 2023 |